{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:10:41Z","timestamp":1778724641393,"version":"3.51.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019751","name":"JSS Academy of Higher Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153846","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:09:35Z","timestamp":1777097375000},"page":"153846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MicroRNA clusters as regulators in progressive fatty liver disease Spectrum: from mechanistic insights to therapeutic opportunities"],"prefix":"10.1016","volume":"819","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-0823","authenticated-orcid":false,"given":"Shreyas Hulusemane","family":"Karunakara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-375X","authenticated-orcid":false,"given":"Prasanna Kumar","family":"Santhekadur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet. : TIG (Trends Genet.)"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/bmc-2013-0015","article-title":"MicroRNA biogenesis and variability","volume":"4","author":"Garc\u00eda-L\u00f3pez","year":"2013","journal-title":"Biomol. Concepts"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153846_bib3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1878-0261.12144","article-title":"Cell-to-cell communication: microRNAs as hormones","volume":"11","author":"Bayraktar","year":"2017","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/bmc-2014-0012","article-title":"Update on non-canonical microRNAs","volume":"5","author":"Abdelfattah","year":"2014","journal-title":"Biomol. Concepts"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153846_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.biochi.2011.06.017","article-title":"Mirtrons: microRNA biogenesis via splicing","volume":"93","author":"Westholm","year":"2011","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153846_bib6","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/nar\/gkz097","article-title":"An estimate of the total number of true human miRNAs","volume":"47","author":"Alles","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153846_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048474","article-title":"A systematic screen reveals MicroRNA clusters that significantly regulate four major signaling pathways","volume":"7","author":"Becker","year":"2012","journal-title":"PLoS One"},{"issue":"D1","key":"10.1016\/j.bbrc.2026.153846_bib8","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"30","key":"10.1016\/j.bbrc.2026.153846_bib9","doi-asserted-by":"crossref","first-page":"21580","DOI":"10.18632\/oncotarget.24662","article-title":"A myriad of roles of miR-25 in health and disease","volume":"9","author":"S\u00e1rk\u00f6zy","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib10","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/brv.12428","article-title":"Clustered miRNAs and their role in biological functions and diseases","volume":"93","author":"Kabekkodu","year":"2018","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"key":"10.1016\/j.bbrc.2026.153846_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1745-6150-8-10","article-title":"Genome-wide analysis reveals downregulation of miR-379\/miR-656 cluster in human cancers","volume":"8","author":"Laddha","year":"2013","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib12","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1038\/s41598-018-26000-8","article-title":"Novel internal regulators and candidate miRNAs within miR-379\/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma","volume":"8","author":"Nayak","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12863-015-0166-3","article-title":"Distribution of miRNA genes in the pig genome","volume":"16","author":"Paczynska","year":"2015","journal-title":"BMC Genet."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/138920209788185225","article-title":"Epigenetic control of MicroRNA expression and aging","volume":"10","author":"Liang","year":"2009","journal-title":"Curr. Genom."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/hep.26573","article-title":"Hepatocyte nuclear factor-4\u03b1 reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region","volume":"58","author":"Yin","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib16","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1074\/jbc.C600252200","article-title":"Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors","volume":"282","author":"Woods","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib17","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/s41467-020-19572-5","article-title":"Germline AGO2 mutations impair RNA interference and human neurological development","volume":"11","author":"Lessel","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153846_bib18","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357250","article-title":"Casein kinase 1 and 2 phosphorylate argonaute proteins to regulate miRNA-mediated gene silencing","volume":"24","author":"Shah","year":"2023","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-020-15598-x","article-title":"XPO5 promotes primary miRNA processing independently of RanGTP","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/1878-0261.13611","article-title":"Regulation and tumor-suppressive function of the miR-379\/miR-656 (C14MC) cluster in cervical cancer","volume":"18","author":"Srinath","year":"2024","journal-title":"Mol. Oncol."},{"issue":"16","key":"10.1016\/j.bbrc.2026.153846_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/eurheartj\/ehu437","article-title":"Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster","volume":"36","author":"Aavik","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153846_bib22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/annrheumdis-2022-222656","article-title":"Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature","volume":"81","author":"Coit","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2026.153846_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1756-0500-3-219","article-title":"Role of DNA methylation in miR-200c\/141 cluster silencing in invasive breast cancer cells","volume":"3","author":"Neves","year":"2010","journal-title":"BMC Res. Notes"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/ijms17030367","article-title":"Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome","volume":"17","author":"Wainwright","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib25","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.bbrc.2026.153846_bib27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in non-alcoholic fatty liver disease","volume":"16","author":"Bugianesi","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","article-title":"Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis","volume":"13","author":"Cusi","year":"2009","journal-title":"Clin. Liver Dis."},{"issue":"39","key":"10.1016\/j.bbrc.2026.153846_bib30","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.20999","article-title":"JNK1 but not JNK2 promotes the development of steatohepatitis in mice","volume":"43","author":"Schattenberg","year":"2006","journal-title":"Hepatology (Baltimore, Md"},{"issue":"5695","key":"10.1016\/j.bbrc.2026.153846_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in non-alcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153846_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153846_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.720900","article-title":"Lack of miR-379\/miR-544 cluster resists high-fat diet-induced obesity and prevents hepatic triglyceride accumulation in mice","volume":"9","author":"Cao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mrd.22957","article-title":"Maternally expressed miR-379\/miR-544 cluster is dispensable for testicular development and spermatogenesis in mice","volume":"85","author":"Cao","year":"2018","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.bbrc.2026.153846_bib41","article-title":"Novel role of quercetin in ameliorating metabolic syndrome via VDR mediated activation of adiponectin\/AdipoR2 signaling","volume":"39","author":"Sannappa Gowda","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2010.01.012","article-title":"miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression","volume":"392","author":"Kim","year":"2010","journal-title":"BBRC (Biochem. Biophys. Res. Commun.)"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153846_bib43","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1742-4658.2009.06967.x","article-title":"A role of miR-27 in the regulation of adipogenesis","volume":"276","author":"Lin","year":"2009","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153846_bib44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/abbs\/gmu036","article-title":"miR-27 inhibits adipocyte differentiation via suppressing CREB expression","volume":"46","author":"Zhu","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153846_bib45","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/oby.21319","article-title":"miR-27 impairs the adipogenic lineage commitment via targeting lysyl oxidase","volume":"23","author":"Chen","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.bbrc.2026.153846_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2916243","article-title":"Up-Regulated MicroRNA-27b promotes adipocyte differentiation via induction of Acyl-CoA thioesterase 2 expression","volume":"2019","author":"Murata","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib47","article-title":"MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/iub.2221","article-title":"Inhibiting miR-27a and miR-142-5p attenuate non-alcoholic fatty liver disease by regulating Nrf2 signaling pathway","volume":"72","author":"Teimouri","year":"2020","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26634","article-title":"Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis","volume":"59","author":"Singaravelu","year":"2014","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.bbrc.2026.153846_bib50","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.18632\/aging.102263","article-title":"MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-\u03b3-mediated PI3K\/AKT signaling","volume":"11","author":"Chen","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.bbrc.2026.153846_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/607692","article-title":"Mmu-miR-27a-5p-Dependent upregulation of MCPIP1 inhibits the inflammatory response in LPS-induced RAW264.7 macrophage cells","volume":"2015","author":"Cheng","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","article-title":"Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation","volume":"583","author":"Ji","year":"2009","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yexcr.2018.03.015","article-title":"Leptin up-regulates microRNA-27a\/b-3p level in hepatic stellate cells","volume":"366","author":"Li","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib54","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1096\/fj.201902438R","article-title":"Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-\u03b21","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153846_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108351","article-title":"Functional study of miR-27a in human hepatic stellate cells by proteomic analysis: comprehensive view and a role in myogenic tans-differentiation","volume":"9","author":"Ji","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","article-title":"Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER","volume":"110","author":"Yang","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology (Baltimore, Md"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/path.5530","article-title":"ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p","volume":"252","author":"Yu","year":"2020","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153846_bib59","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1002\/jcb.26583","article-title":"Association of rno-miR-183-96-182 cluster with diethyinitrosamine induced liver fibrosis in wistar rats","volume":"119","author":"Chandel","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.bbrc.2026.153846_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310858","article-title":"Cisplatin in liver cancer therapy","volume":"24","author":"Hamaya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.bbrc.2026.153846_bib61","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41388-025-03373-5","article-title":"MYCBP2-mediated HNF4\u03b1 ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153846_bib62","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00096.2025","article-title":"Role of long chain Acyl-CoA synthetases in MASH-driven hepatocellular carcinoma and ferroptosis","author":"Classon","year":"2025","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-025-02370-2","article-title":"Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153846_bib64","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/carcin\/bgv112","article-title":"MiR-17-92 cluster promotes hepatocarcinogenesis","volume":"36","author":"Zhu","year":"2015","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11943-1","article-title":"MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance","volume":"7","author":"Awan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/bjc.2014.547","article-title":"Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma","volume":"112","author":"Yang","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"36","key":"10.1016\/j.bbrc.2026.153846_bib67","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1038\/onc.2015.517","article-title":"Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression","volume":"35","author":"Urtasun","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13046-018-0698-2","article-title":"C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153846_bib69","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","article-title":"Imbalance of TGF-\u03b21\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness","volume":"29","author":"Ning","year":"2021","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.bbrc.2026.153846_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.927079","article-title":"The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: a meta-analysis","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153846_bib71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1827.2010.02526.x","article-title":"Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development","volume":"60","author":"Shigoka","year":"2010","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/HEP.0000000000000435","article-title":"Extrachromosomal circular MiR-17-92 amplicon promotes HCC","volume":"79","author":"Zou","year":"2024","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.bbrc.2026.153846_bib73","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.3748\/wjg.v22.i22.5183","article-title":"miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma","volume":"22","author":"Yen","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153846_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13000-014-0226-4","article-title":"Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma","volume":"9","author":"Li","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153846_bib75","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.18632\/aging.101510","article-title":"Anillin is required for tumor growth and regulated by miR-15a\/miR-16-1 in HBV-related hepatocellular carcinoma","volume":"10","author":"Lian","year":"2018","journal-title":"Aging"},{"issue":"25","key":"10.1016\/j.bbrc.2026.153846_bib76","doi-asserted-by":"crossref","first-page":"18484","DOI":"10.1074\/jbc.M113.458158","article-title":"Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a\/miR-16-1 in hepatocytes","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib77","first-page":"105","article-title":"Plasma microRNA-15a\/16-1-based machine learning for early detection of hepatitis B virus-related hepatocellular carcinoma","volume":"8","author":"Wei","year":"2024","journal-title":"Liver research (Beijing, China)"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib78","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.gastro.2021.10.015","article-title":"MicroRNA-15a\/16-1 prevents hepatocellular carcinoma by disrupting the communication between kupffer cells and regulatory T cells","volume":"162","author":"Liu","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13104-024-06876-8","article-title":"Analysis of miR-497\/195 cluster identifies new therapeutic targets in cervical cancer","volume":"17","author":"Karunakara","year":"2024","journal-title":"BMC Res. Notes"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153846_bib80","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12033-023-01000-w","article-title":"miR-497\/195 cluster affects the development of colorectal cancer by targeting FRA1","volume":"66","author":"Huang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153846_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102941","article-title":"GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma","volume":"59","author":"Negroni","year":"2020","journal-title":"EBioMedicine"},{"issue":"24","key":"10.1016\/j.bbrc.2026.153846_bib82","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic ras initiates a tumor-promoting feed-forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes & development"},{"issue":"20","key":"10.1016\/j.bbrc.2026.153846_bib83","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/onc.2012.266","article-title":"RREB1 repressed miR-143\/145 modulates KRAS signaling through downregulation of multiple targets","volume":"32","author":"Kent","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084311","article-title":"The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195\/497 cluster","volume":"9","author":"Itesako","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153846_bib85","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1476-4598-13-220","article-title":"miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer","volume":"13","author":"Yan","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-15-0854","article-title":"Stromal expression of miR-143\/145 promotes neoangiogenesis in lung cancer development","volume":"6","author":"Dimitrova","year":"2016","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153846_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114420","article-title":"MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer","volume":"9","author":"Su","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060155","article-title":"The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma","volume":"8","author":"Furuta","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153846_bib89","first-page":"6115","article-title":"Expression of the microRNA-143\/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B","volume":"15","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.31557\/APJCP.2020.21.2.555","article-title":"Serum microRNA let-7a-1\/let-7d\/let-7f and miRNA 143\/145 gene expression profiles as potential biomarkers in HCV induced hepatocellular carcinoma","volume":"21","author":"Aly","year":"2020","journal-title":"Asian Pac. J. Cancer Prev. APJCP : Asian Pac. J. Cancer Prev. APJCP"},{"issue":"36","key":"10.1016\/j.bbrc.2026.153846_bib91","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41388-024-03115-z","article-title":"CRISPR-based dissection of microRNA-23a \u223c 27a \u223c 24-2 cluster functionality in hepatocellular carcinoma","volume":"43","author":"Cui","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib92","doi-asserted-by":"crossref","first-page":"929","DOI":"10.18632\/oncotarget.6137","article-title":"miR-214\/199a\/199a\u2217 cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153846_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109782","article-title":"The miR-545\/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbrc.2026.153846_bib94","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1002\/jcp.29538","article-title":"The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma","volume":"235","author":"Rui","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ijc.31857","article-title":"A novel SOCS5\/miR-18\/miR-25 axis promotes tumorigenesis in liver cancer","volume":"144","author":"Sanchez-Mejias","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102450","article-title":"Genes of DLK1-DIO3 locus and miR-379\/656 cluster is a potential diagnostic and prognostic marker in patients with hepatocellular carcinoma: a systems biology Study","volume":"15","author":"Karunakara","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12935-023-03002-9","article-title":"EZH2-mediated epigenetic silencing of tumor-suppressive let-7c\/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis","volume":"23","author":"Wu","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2015.03.023","article-title":"Wnt\/\u03b2-Catenin activates MiR-183\/96\/182 expression in hepatocellular carcinoma that promotes cell invasion","volume":"362","author":"Leung","year":"2015","journal-title":"Cancer letters"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib99","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.26369","article-title":"MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.bbrc.2026.153846_bib100","first-page":"7863","article-title":"MiR-302 a\/b\/c suppresses tumor angiogenesis in hepatocellular carcinoma by targeting MACC1","volume":"23","author":"Cao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib101","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/ijc.23580","article-title":"Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells","volume":"123","author":"Huang","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153846_bib102","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.7150\/jca.29207","article-title":"Clustered microRNAs hsa-miR-221-3p\/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"issue":"17","key":"10.1016\/j.bbrc.2026.153846_bib103","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1074\/jbc.M111.321646","article-title":"Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor \u03baB and miR-221","volume":"287","author":"Santhekadur","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm5030030","article-title":"Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Afonso","year":"2016","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153846_bib105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib106","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","article-title":"The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a phase 3 biomarker Study in the United States","volume":"21","author":"Tayob","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. : the official clinical practice journal of the American Gastroenterological Association"},{"key":"10.1016\/j.bbrc.2026.153846_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.753885","article-title":"Established tumour biomarkers predict cardiovascular events and mortality in the general population","volume":"8","author":"Bracun","year":"2021","journal-title":"Frontiers in cardiovascular medicine"},{"key":"10.1016\/j.bbrc.2026.153846_bib108","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fonc.2020.01316","article-title":"New blood biomarkers for the diagnosis of AFP-Negative hepatocellular carcinoma","volume":"10","author":"Wang","year":"2020","journal-title":"Frontiers in oncology"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib109","doi-asserted-by":"crossref","first-page":"C588","DOI":"10.1152\/ajpcell.00253.2022","article-title":"Circulating miRNAs associated with non-alcoholic fatty liver disease","volume":"324","author":"Atic","year":"2023","journal-title":"American journal of physiology. Cell physiology"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153846_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105192","article-title":"A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of non-alcoholic fatty liver disease","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219412","article-title":"Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease","volume":"15","author":"Okamoto","year":"2020","journal-title":"PLoS One"},{"issue":"35","key":"10.1016\/j.bbrc.2026.153846_bib112","doi-asserted-by":"crossref","first-page":"30706","DOI":"10.1074\/jbc.M111.229831","article-title":"DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival","volume":"286","author":"Luk","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153846_bib113","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1478-3231.2012.02795.x","article-title":"MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma","volume":"32","author":"Augello","year":"2012","journal-title":"Liver Int. : official journal of the International Association for the Study of the Liver"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153846_bib114","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1186\/s12885-017-3860-x","article-title":"Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues","volume":"17","author":"Tang","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153846_bib115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153846_bib116","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/17425247.2025.2466767","article-title":"GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases","volume":"22","author":"Qin","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153846_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102184","article-title":"Oligonucleotide therapies for non-alcoholic steatohepatitis","volume":"35","author":"Li","year":"2024","journal-title":"Molecular therapy. Nucleic acids"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:52:29Z","timestamp":1778723549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26006108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":117,"alternative-id":["S0006291X26006108"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153846","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA clusters as regulators in progressive fatty liver disease Spectrum: from mechanistic insights to therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153846"}}